Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Radiation Oncology-Biology Integration Network (ROBIN)…

U.S. National Institutes of Health·United States of America

Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Closes 1/24/2027$500k – $5MGrants Notice
Get bids like this by emailBid source

Description

The National Cancer Institute (NCI) intends to support the Radiation Oncology-Biology Integration Network (ROBIN) through this Notice of Funding Opportunity (NOFO). The network model will sustain an agile and effective national radiation oncology infrastructure that collectively addresses critical hypothesis-based translational research on the biological basis of responses in cancer patients who undergo radiation treatments. The key objectives of ROBIN include understanding how tumors and normal tissues change biologically during radiation therapy, generating foundational knowledge that can improve radiation-based cancer care, and identifying new opportunities for combining radiation with drugs and other therapies. • The network will focus on understanding the biological basis of responses in cancer patients who undergo radiation treatments. • The network will generate foundational knowledge that can improve radiation-based cancer care. • The network will identify new opportunities for combining radiation with drugs and other therapies. • The network will strengthen the radiation oncology workforce by integrating expertise in biology, clinical oncology, imaging, dosimetry, omics, biospecimen science, and data science.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

[email protected]

Key dates

Opened
6/2/2026
Closes
1/24/2027
Projected award
9/1/2027

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-CA-27-003

Budget estimate

$500,000 – $5,000,000

The budget for this grant is not explicitly stated in the document, but based on the scope of the project, it can be estimated to be in the range of $500,000 to $5 million per year, considering the funding for a cooperative agreement. The actual budget may vary depending on the number of awards, the duration of the project, and the specific requirements of the grant.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 81%

RNomics Outreach and Coordination (ROC) Center

Closes 1/31/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

81% match

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Closes 1/11/2027Opened 9/17/2025

U.S. National Institutes of Health·United States of America

81% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 9/25/2028Opened 11/26/2025

U.S. National Institutes of Health·United States of America

81% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

80% match

The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

Closes 11/22/2028Opened 6/16/2025

U.S. National Institutes of Health·United States of America

80% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 1/24/2027Opened 3/10/2026

U.S. National Institutes of Health·United States of America

80% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

79% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

79% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

79% match

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 1/13/2026

U.S. National Institutes of Health·United States of America

79% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

79% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024

U.S. National Institutes of Health·United States of America

79% match

Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

Closes 1/25/2027Opened 8/28/2025

U.S. National Institutes of Health·United States of America

79% match

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/24/2026

U.S. National Institutes of Health·United States of America

78% match

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

Closes 11/15/2027Opened 12/16/2024

U.S. National Institutes of Health·United States of America

78% match

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Closes 5/25/2027Opened 2/11/2026

U.S. National Institutes of Health·United States of America

78% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

78% match

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/29/2023

U.S. National Institutes of Health·United States of America

78% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

78% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

78% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

78% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

78% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025